Recent Analyst Forecasts and Stock Ratings
Y-mAbs Therapeutics, Inc. FAQ's
Y-mAbs Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, Truist Financial, H.C. Wainwright, Wedbush in the past 90 days.
Y-mAbs Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, Truist Financial, H.C. Wainwright, Wedbush in the past 90 days.